BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,830,597 | -17.2% | 207,488 | 0.0% | 0.04% | -12.8% |
| Q2 2023 | $9,453,153 | +12.3% | 207,488 | 0.0% | 0.05% | +14.6% |
| Q1 2023 | $8,415,713 | -29.3% | 207,488 | -11.1% | 0.04% | -26.8% |
| Q4 2022 | $11,897,774 | -19.6% | 233,427 | -15.0% | 0.06% | -17.6% |
| Q3 2022 | $14,795,000 | -16.1% | 274,698 | 0.0% | 0.07% | -10.5% |
| Q2 2022 | $17,644,000 | -14.9% | 274,698 | +2.8% | 0.08% | -2.6% |
| Q1 2022 | $20,727,000 | +4.2% | 267,301 | +15.4% | 0.08% | +5.4% |
| Q4 2021 | $19,889,000 | -9.3% | 231,702 | -15.0% | 0.07% | -22.9% |
| Q3 2021 | $21,928,000 | -48.6% | 272,631 | -48.6% | 0.10% | -50.8% |
| Q2 2021 | $42,681,000 | +20.8% | 530,202 | +26.5% | 0.20% | +1.0% |
| Q1 2021 | $35,336,000 | +6.1% | 418,970 | +1.0% | 0.19% | 0.0% |
| Q4 2020 | $33,298,000 | -4.6% | 414,982 | -4.3% | 0.19% | -14.2% |
| Q3 2020 | $34,887,000 | -16.6% | 433,809 | -10.7% | 0.22% | -24.0% |
| Q2 2020 | $41,834,000 | -25.9% | 485,878 | -30.2% | 0.30% | -33.2% |
| Q1 2020 | $56,483,000 | -29.7% | 695,693 | -27.6% | 0.44% | +11.6% |
| Q4 2019 | $80,385,000 | -4.9% | 961,318 | -0.5% | 0.40% | -13.7% |
| Q3 2019 | $84,494,000 | +9.1% | 965,979 | +2.1% | 0.46% | +7.0% |
| Q2 2019 | $77,449,000 | -14.5% | 945,658 | -15.1% | 0.43% | -23.9% |
| Q1 2019 | $90,610,000 | +18.0% | 1,114,378 | -4.5% | 0.56% | +11.4% |
| Q4 2018 | $76,808,000 | -26.5% | 1,166,933 | -13.9% | 0.51% | -11.8% |
| Q3 2018 | $104,513,000 | +5.1% | 1,355,732 | +0.7% | 0.58% | -5.4% |
| Q2 2018 | $99,414,000 | +15.3% | 1,346,341 | +1.6% | 0.61% | +8.4% |
| Q1 2018 | $86,210,000 | -0.7% | 1,325,483 | -1.4% | 0.56% | +26.6% |
| Q4 2017 | $86,854,000 | +6.7% | 1,343,656 | +3.5% | 0.44% | -29.7% |
| Q3 2017 | $81,425,000 | -2.1% | 1,297,609 | -5.5% | 0.63% | +2.6% |
| Q2 2017 | $83,133,000 | +4.9% | 1,373,191 | -10.1% | 0.61% | -1.6% |
| Q1 2017 | $79,222,000 | +20.3% | 1,527,607 | +2.9% | 0.62% | +19.3% |
| Q4 2016 | $65,843,000 | -17.5% | 1,484,951 | -11.5% | 0.52% | -8.2% |
| Q3 2016 | $79,831,000 | +48.9% | 1,677,124 | +41.5% | 0.57% | +51.6% |
| Q2 2016 | $53,602,000 | +1888.2% | 1,185,362 | +1706.5% | 0.38% | +1988.9% |
| Q1 2016 | $2,696,000 | +14.9% | 65,618 | +6.7% | 0.02% | +20.0% |
| Q4 2015 | $2,347,000 | +16.1% | 61,525 | 0.0% | 0.02% | +7.1% |
| Q3 2015 | $2,021,000 | -53.0% | 61,525 | +0.0% | 0.01% | -48.1% |
| Q2 2015 | $4,301,000 | -3.4% | 61,505 | -5.3% | 0.03% | -3.6% |
| Q1 2015 | $4,451,000 | -6.5% | 64,975 | +0.1% | 0.03% | -9.7% |
| Q4 2014 | $4,759,000 | +2.7% | 64,937 | +0.5% | 0.03% | 0.0% |
| Q3 2014 | $4,636,000 | -0.7% | 64,600 | 0.0% | 0.03% | +3.3% |
| Q2 2014 | $4,671,000 | +5.8% | 64,600 | +7.7% | 0.03% | +7.1% |
| Q1 2014 | $4,415,000 | +5.8% | 60,000 | 0.0% | 0.03% | +3.7% |
| Q4 2013 | $4,173,000 | +5.9% | 60,000 | 0.0% | 0.03% | +8.0% |
| Q3 2013 | $3,941,000 | -5.2% | 60,000 | 0.0% | 0.02% | -7.4% |
| Q2 2013 | $4,156,000 | – | 60,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |